18th Mar 2025 10:38 am |
RNS |
Placing to raise £250,000 |
3rd Feb 2025 7:00 am |
RNS |
IB Expands Distribution with Blackford |
22nd Jan 2025 7:00 am |
RNS |
Operations Update |
10th Jan 2025 7:49 am |
RNS |
IB and Prism Secure First Installation |
20th Nov 2024 7:00 am |
RNS |
Imaging Biometrics Expands Distribution |
19th Nov 2024 11:27 am |
RNS |
Board Changes |
5th Nov 2024 7:00 am |
RNS |
New Patent Application and Trading Update |
15th Oct 2024 10:28 am |
RNS |
Holding(s) in Company |
14th Oct 2024 12:08 pm |
RNS |
Holding(s) in Company |
14th Oct 2024 12:05 pm |
RNS |
PDMR dealing and TR1 announcement |
11th Oct 2024 10:42 am |
RNS |
Acquisition of Interest by Braveheart |
25th Jun 2024 9:59 am |
RNS |
IB Opens Expanded Access Program |
14th Jun 2024 8:38 am |
RNS |
Clinical Trial Updates |
29th May 2024 3:08 pm |
RNS |
Result of AGM |
23rd May 2024 7:00 am |
RNS |
Major East Coast Health System Chooses IB Nimble |
20th May 2024 7:10 am |
RNS |
Second FDA Rare Pediatric Disease Designation |
17th May 2024 7:00 am |
RNS |
IB Software Enhances Clinical Decision-Making |
10th May 2024 8:15 am |
RNS |
Rare Pediatric Disease Designation Granted to GaM |
2nd May 2024 12:47 pm |
RNS |
IB Announces Expanded Access Program for GaM |
29th Apr 2024 3:26 pm |
RNS |
Publication of Annual Report |
5th Mar 2024 7:00 am |
RNS |
Grant of Options |
1st Mar 2024 8:22 am |
RNS |
Holding(s) in Company |
1st Mar 2024 8:20 am |
RNS |
Holding(s) in Company |
26th Feb 2024 7:00 am |
RNS |
Result of Broker Option and Total Voting Rights |
22nd Feb 2024 7:00 am |
RNS |
Placing and Broker Option |
9th Feb 2024 12:49 pm |
RNS |
FDA Application Update |
2nd Feb 2024 8:39 am |
RNS |
IB awarded a $100,000 grant |
22nd Jan 2024 10:05 am |
RNS |
Holding(s) in Company |
15th Jan 2024 7:01 am |
RNS |
Director Dealings and Conversion of CLNs |
15th Jan 2024 7:00 am |
RNS |
Holding(s) in Company |
10th Jan 2024 7:00 am |
RNS |
IB Launching an Expanded Access Program for GaM |
19th Dec 2023 2:29 pm |
RNS |
Imaging Biometrics granted FDA “Fast-Track†|
5th Dec 2023 10:58 am |
RNS |
IQ-AI Announces Positive Interim Phase 1 Results |
20th Nov 2023 1:42 pm |
RNS |
Holding(s) in Company |
9th Nov 2023 11:38 am |
RNS |
Director Dealing and Conversion of CLNs |
8th Nov 2023 10:59 am |
RNS |
Application for Pediatric Rare Disease Designation |
6th Nov 2023 1:02 pm |
RNS |
Holding(s) in Company |
18th Oct 2023 2:29 pm |
RNS |
Update Regarding Imaging Biometrics LLC |
13th Oct 2023 8:55 am |
RNS |
IB Letter to Shareholders |
9th Oct 2023 7:00 am |
RNS |
Orphan Drug Status to GaM and Total Voting Rights |